Tacrolimus for Crohn's Disease User Reviews
Brand names: Prograf, Envarsus XR, Astagraf XL
- Anonymous
- Taken for 1 to 6 months
- May 3, 2017
"I have an autoimmune condition, Anti-Synthetase Syndrome, ILD, and dermatomyositis. I have been on tacrolimus for approximately 2 months. I was on it previously as an interim drug before I received rituximab, and before that, I had nine rounds of cyclophosphamide. I have also tried mycophenolate while I was having rituximab."
- Sen...
- July 7, 2018
"Tacrolimus has too many real side effects. Would the doctor prescribe this to someone they love in their family? I can't believe doctors prescribe this stuff to patients. This stuff is bad. Period."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Crohn's Disease
Symptoms and treatments
Medicine.com guides (external)
More about tacrolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (49)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Patient resources
- Tacrolimus oral and injection drug information
- Tacrolimus (Intravenous) (Advanced Reading)
- Tacrolimus (Oral) (Advanced Reading)
- Tacrolimus Capsules
- Tacrolimus Extended-Release Tablets
Other brands
Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Other brands
Prograf, Envarsus XR, Astagraf XL
"I was in the original FDA FK506 study as a pre-transplant patient (Primary Sclerosing Cholangitis). I had been given 6 years to have a liver transplant. My liver numbers were 3-4 digits, and I was becoming very ill. My dosage was stabilized at 3 mgs, and my numbers have decreased to normal. I have been on this medicine since 10 '92 and still no transplant. The medicine has slowed the progress of PSC drastically. I see it is used for Crohn's, but nothing is listed for liver diseases. Did they ever evaluate the trial results from the early 90's? My current insurance will not approve the drug for me for this reason. This might be the result of the trial www.ncbi.nlm.nih.gov/pmc/articles/PMC2982698/ or a similar one."